<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02812953</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01832-47</org_study_id>
    <nct_id>NCT02812953</nct_id>
  </id_info>
  <brief_title>Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention</brief_title>
  <acronym>BIO TAVI</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Action, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Action, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A sample of plasma and whole blood will be obtained at 4 time points (pre-procedural, early
      post-procedural, at hospital discharge and during an eventual visite at 3 or 6 months
      post-procedural). Test for platelet reactivity (LTA, light transmittance aggregometry and
      Elisa PRI, Platelet reactivity index), multimeric VWF (von Willebrand factor) and blood level
      of NET: neutrophil extracellular traps(flow cytometry and ELISA) analyses will be performed
      at the time of blood sampling. Aliquots of plasma will be stored and frozen for further
      analyses
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are two major objectives:

        -  To correlate changes in VWF, platelet reactivity and blood level of NET after TAVR with
           clinical outcomes

        -  To correlate changes in VWF, platelet reactivity and blood level of NET with
           antithrombotic regimens after TAVR (direct anticoagulants apixaban versus standard of
           care, ie Vitamin K antagonist or antiplatelet therapy).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>12 months</time_frame>
    <description>stroke/transient ischemic attack; acute coronary syndrome; hospitalization for cardiac insufficiency, cardiovascular or unexplained deaths will be collected at 12 month by phone contact with the patient or his/her relatives or his/her treating physician</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>12 months</time_frame>
    <description>Serious bleeding event (BLEED II or more) will be collected at 12 month by phone contact with the patient or his/her relatives or his/her treating physician</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean pressure transprosthetic gradient</measure>
    <time_frame>within ten days after valve replacement</time_frame>
    <description>value of the mean pressure transprosthetic gradient after TAVR procedure will be assessed by TTE (transthoracic echography) or TOE (transesophageal echography)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Transcatheter Aortic Valve Replacement</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Platelet poor plasma for von Willebrandt Factor further evaluation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient undergoing TAVR
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient undergoing TAVR intervention

          -  agreement given

        Exclusion Criteria:

          -  severe thrombopenia ( &lt;40.10^9/L)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean Philippe COLLET, MD, PhD</last_name>
    <phone>+33142162962</phone>
    <email>jean-philippe.collet@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine Brugier, PhD</last_name>
    <phone>+33142162918</phone>
    <email>delphine.brugier-ext@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>December 21, 2017</last_update_submitted>
  <last_update_submitted_qc>December 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

